Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fat Emulsions, Intravenous | 5 | 2025 | 79 | 2.780 |
Why?
|
| Parenteral Nutrition | 7 | 2025 | 199 | 2.470 |
Why?
|
| Cholestasis | 5 | 2025 | 157 | 2.270 |
Why?
|
| Soybean Oil | 7 | 2025 | 70 | 1.810 |
Why?
|
| Bile Acids and Salts | 7 | 2025 | 255 | 1.720 |
Why?
|
| Phytosterols | 3 | 2021 | 28 | 1.370 |
Why?
|
| Liver Diseases | 3 | 2023 | 385 | 1.130 |
Why?
|
| Phospholipids | 2 | 2019 | 104 | 1.090 |
Why?
|
| Liver | 6 | 2025 | 1797 | 1.070 |
Why?
|
| Fibroblast Growth Factors | 4 | 2023 | 165 | 0.950 |
Why?
|
| Swine | 11 | 2025 | 1179 | 0.780 |
Why?
|
| Biliary Atresia | 1 | 2025 | 206 | 0.740 |
Why?
|
| Emulsions | 5 | 2025 | 70 | 0.730 |
Why?
|
| Fish Oils | 3 | 2021 | 80 | 0.700 |
Why?
|
| Infant, Premature | 5 | 2023 | 843 | 0.660 |
Why?
|
| Lipid Metabolism | 3 | 2020 | 382 | 0.640 |
Why?
|
| Vitamin E | 1 | 2019 | 63 | 0.620 |
Why?
|
| Rifampin | 1 | 2019 | 120 | 0.590 |
Why?
|
| Kupffer Cells | 1 | 2017 | 20 | 0.560 |
Why?
|
| Endotoxins | 1 | 2017 | 48 | 0.550 |
Why?
|
| Triglycerides | 3 | 2019 | 617 | 0.550 |
Why?
|
| Animals, Newborn | 5 | 2025 | 1033 | 0.540 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2022 | 420 | 0.520 |
Why?
|
| Hepatocytes | 1 | 2017 | 239 | 0.490 |
Why?
|
| Inflammation | 1 | 2017 | 1522 | 0.320 |
Why?
|
| Docosahexaenoic Acids | 2 | 2019 | 66 | 0.270 |
Why?
|
| Animals | 13 | 2025 | 34850 | 0.270 |
Why?
|
| Disease Models, Animal | 3 | 2025 | 4690 | 0.250 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2025 | 47 | 0.230 |
Why?
|
| Milk, Human | 2 | 2023 | 308 | 0.210 |
Why?
|
| beta Carotene | 1 | 2023 | 34 | 0.200 |
Why?
|
| Infant, Newborn | 6 | 2023 | 8548 | 0.190 |
Why?
|
| Endocrine System | 1 | 2022 | 18 | 0.190 |
Why?
|
| Parturition | 1 | 2022 | 66 | 0.190 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2022 | 111 | 0.190 |
Why?
|
| Hydrocortisone | 1 | 2022 | 226 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2022 | 175 | 0.170 |
Why?
|
| Probiotics | 1 | 2023 | 226 | 0.170 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2023 | 248 | 0.160 |
Why?
|
| Signal Transduction | 3 | 2022 | 4720 | 0.160 |
Why?
|
| Hyperbilirubinemia | 1 | 2019 | 42 | 0.160 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2019 | 50 | 0.160 |
Why?
|
| Glucuronosyltransferase | 1 | 2019 | 62 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2021 | 325 | 0.150 |
Why?
|
| Sus scrofa | 1 | 2019 | 121 | 0.150 |
Why?
|
| Intestines | 1 | 2021 | 606 | 0.140 |
Why?
|
| Glucose | 1 | 2022 | 871 | 0.140 |
Why?
|
| Homeostasis | 1 | 2021 | 722 | 0.130 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2017 | 18 | 0.130 |
Why?
|
| Palmitic Acid | 1 | 2016 | 29 | 0.130 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2016 | 32 | 0.130 |
Why?
|
| Humans | 12 | 2023 | 132247 | 0.130 |
Why?
|
| Isoflavones | 1 | 2016 | 43 | 0.120 |
Why?
|
| Meta-Analysis as Topic | 1 | 2017 | 172 | 0.120 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 306 | 0.120 |
Why?
|
| Premature Birth | 1 | 2020 | 418 | 0.120 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2017 | 123 | 0.120 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2023 | 810 | 0.120 |
Why?
|
| Microbiota | 1 | 2020 | 434 | 0.110 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 255 | 0.110 |
Why?
|
| Child Development | 1 | 2017 | 271 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2016 | 356 | 0.110 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2017 | 211 | 0.110 |
Why?
|
| Metabolic Syndrome | 1 | 2016 | 365 | 0.100 |
Why?
|
| Sepsis | 1 | 2017 | 516 | 0.090 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3046 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 1249 | 0.090 |
Why?
|
| Biomarkers | 1 | 2021 | 3404 | 0.090 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2017 | 554 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2442 | 0.070 |
Why?
|
| Male | 3 | 2025 | 65012 | 0.060 |
Why?
|
| Female | 4 | 2025 | 70785 | 0.060 |
Why?
|
| Pregnancy | 3 | 2022 | 7557 | 0.050 |
Why?
|
| Zeaxanthins | 1 | 2023 | 9 | 0.050 |
Why?
|
| Lutein | 1 | 2023 | 14 | 0.050 |
Why?
|
| Bifidobacterium longum subspecies infantis | 1 | 2023 | 5 | 0.050 |
Why?
|
| Vitamin A | 1 | 2023 | 56 | 0.050 |
Why?
|
| Infant Formula | 1 | 2023 | 98 | 0.050 |
Why?
|
| Carotenoids | 1 | 2023 | 79 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 10945 | 0.050 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2021 | 34 | 0.050 |
Why?
|
| Vagina | 1 | 2022 | 205 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2017 | 13027 | 0.040 |
Why?
|
| Olive Oil | 1 | 2019 | 24 | 0.040 |
Why?
|
| Gestational Age | 1 | 2022 | 1227 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2021 | 417 | 0.040 |
Why?
|
| Oleic Acid | 1 | 2016 | 18 | 0.030 |
Why?
|
| Genistein | 1 | 2016 | 39 | 0.030 |
Why?
|
| Hep G2 Cells | 1 | 2016 | 94 | 0.030 |
Why?
|
| Body Composition | 1 | 2019 | 550 | 0.030 |
Why?
|
| Incidence | 1 | 2023 | 3376 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 755 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2016 | 439 | 0.020 |
Why?
|
| Infant | 1 | 2023 | 13049 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 3194 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 4758 | 0.020 |
Why?
|